4-3489777-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7

The NM_173660.5(DOK7):​c.753G>T​(p.Ala251Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000211 in 1,420,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A251A) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

DOK7
NM_173660.5 synonymous

Scores

1
3
10

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:2

Conservation

PhyloP100: -2.31

Publications

10 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.108039826).
BP6
Variant 4-3489777-G-T is Benign according to our data. Variant chr4-3489777-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2934861.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.32 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_173660.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
NM_173660.5
MANE Select
c.753G>Tp.Ala251Ala
synonymous
Exon 6 of 7NP_775931.3
DOK7
NM_001256896.2
c.-178G>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 4NP_001243825.1
DOK7
NM_001164673.2
c.742G>Tp.Gly248Trp
missense
Exon 6 of 7NP_001158145.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
ENST00000340083.6
TSL:1 MANE Select
c.753G>Tp.Ala251Ala
synonymous
Exon 6 of 7ENSP00000344432.5
DOK7
ENST00000513995.1
TSL:1
n.411G>T
non_coding_transcript_exon
Exon 2 of 3
DOK7
ENST00000515886.5
TSL:2
c.-178G>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 4ENSP00000492194.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
183538
AF XY:
0.0000102
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000132
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000211
AC:
3
AN:
1420692
Hom.:
0
Cov.:
32
AF XY:
0.00000285
AC XY:
2
AN XY:
702746
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32714
American (AMR)
AF:
0.00
AC:
0
AN:
39220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25352
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37534
South Asian (SAS)
AF:
0.0000124
AC:
1
AN:
80884
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49542
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
0.00000183
AC:
2
AN:
1090924
Other (OTH)
AF:
0.00
AC:
0
AN:
58804
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DOK7-related disorder Uncertain:1
May 16, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The DOK7 c.742G>T variant is predicted to result in the amino acid substitution p.Gly248Trp. Of note, in the primary transcript listed in the Human Gene Mutation Database (http://www.hgmd.cf.ac.uk/ac/index.php; NM_173660), this variant does not result in an amino acid change (c.753G>T, p.=). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0041% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Inborn genetic diseases Benign:1
Aug 27, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Benign:1
Jan 16, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
0.040
CADD
Benign
0.062
DANN
Benign
0.54
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0081
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.11
T
MetaSVM
Uncertain
-0.022
T
PhyloP100
-2.3
PROVEAN
Benign
0.25
N
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D
Vest4
0.33
MVP
0.48
ClinPred
0.034
T
GERP RS
-1.9
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59932476; hg19: chr4-3491504; API